UniPR129 is a potent Eph/ephrin antagonist. UniPR129 has the potential for the research of cancer disease[1].
[1]. Giorgio C, et al. Pharmacological evaluation of new bioavailable small molecules targeting Eph/ephrin interaction. Biochem Pharmacol. 2018;147:21-29.
















